Similar articles

• [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].

  Tillement JP, Duché JC, Barré J. Tillement JP, et al. Bull Acad Natl Med. 2006 Apr-May;190(4-5):935-46; discussion 946-7. Bull Acad Natl Med. 2006. PMID: 17195618 French.
• [Characterization of propofol binding to plasma proteins and possible interactions].

  Garrido MJ, Jiménez RM, Rodríguez-Sasiaín JM, Aguirre C, Aguilera L, Calvo R. Garrido MJ, et al. Rev Esp Anestesiol Reanim. 1994 Nov-Dec;41(6):308-12. Rev Esp Anestesiol Reanim. 1994. PMID: 7838996 Spanish.
• [Drug interactions through influencing plasma-protein binding].

  Ohnhaus EE. Ohnhaus EE. Internist (Berl). 1979 May;20(5):225-8. Internist (Berl). 1979. PMID: 376478 German. No abstract available.
• Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.

  Alván G. Alván G. Prog Clin Biol Res. 1986;214:345-55. Prog Clin Biol Res. 1986. PMID: 3523512 Review. No abstract available.
• Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.

  Østergaard J, Heegaard NH. Østergaard J, et al. Electrophoresis. 2003 Sep;24(17):2903-13. doi: 10.1002/elps.200305526. Electrophoresis. 2003. PMID: 12973793 Review.